Connect with us

Technology

Meshy releases Meshy 7, a new foundation model that sets a new bar for image-3D alignment

Published

on

Meshy 7 is built around a single standard: the 3D result should agree with the image the user brought. Meshy is also publishing how it measures that agreement — geometry scored directly against reference models held out of training, not by human preference or a vision-language judge.

SILICON VALLEY, Calif., Aug. 12, 2026 /PRNewswire/ — Meshy has released Meshy 7, its new image-to-3D foundation model, together with the method behind a new 3D geometry alignment benchmark and its first results.

WHY ALIGNMENT MATTERS NOW

The first problem with image-to-3D was whether a model could produce a usable asset at all. Broken surfaces, scrambled structure and missing limbs are now rare enough among leading models that not breaking differentiates very little.

So the question that matters has changed. An asset can look entirely reasonable and still fail to reproduce the reference: a body slightly too wide, a hand shifted out of place, an engraved line from the source image simply gone. Nothing is obviously wrong, and it is not what the user designed. That is alignment, and it separates a good 3D model from one that merely does not break.

INDUSTRY-LEADING ALIGNMENT

Given a single input image, Meshy 7 leads every model tested on all three aspects of alignment: 81.0% on overall proportion, 79.7% on spatial distribution, 59.8% on surface details — measured against four competing 3D foundation models on reference 3D models excluded from training, where 100% is the reference measured against itself. The pattern holds under the front view, the strictest condition, where Meshy 7 leads on aggregate and on each metric individually.

The lead is widest where the problem is hardest. Overall proportion is close across leading models now. Surface details is not — under single-view input no model tested reaches 60% — and this is where Meshy 7 pulls furthest ahead: 5.3 points clear of the closest competitor, more than twice its margin on either of the other two aspects. That is the shape of a real lead: not a fraction of a point where the field is already bunched together, but daylight on the dimension nobody has solved.

With four views the field converges: every model improves, and extra views help most on spatial distribution and surface details, the dimensions most affected by hidden geometry. The leaders end up within roughly two points of one another, and Meshy 7’s single-view lead is large enough that the closest competitor catches up rather than clearly overtakes it. Single-view input is where systems separate — and it is the condition most users are in.

Compared with Meshy 6, Meshy 7 improves alignment clearly on both geometry and texture. The benchmark above covers geometry; texture is measured separately.
 

WHERE THE DIFFERENCE SHOWS

Faces. A small geometric change is enough to alter an expression, which makes faces one of the hardest alignment tests. Across a set of portrait busts, Meshy 7 does not settle for a generic face: cheeks lift and laugh lines deepen on a smile, the brow tightens and the mouth turns down on a stern look, the face relaxes on closed eyes — while headscarf, knot and clothing stay stable.Part relationships. A mechanical object only reads as mechanical when every component sits where it belongs. On a clockwork owl of layered wing armour, exposed gears and thin legs, Meshy 7 keeps the parts distinct and placed as the concept places them, rather than collapsing the design into a bird-shaped mass.Dense surface relief. A jade medallion is almost entirely shallow relief — a dragon coiling the outer ring, dense cloud pattern, a raised centre motif, all on a nearly flat disc. Meshy 7 keeps the pattern continuous rather than fragmented, at the depth the image gives it.

Three changes got it there. The image encoder now reads the input at multiple scales and accepts higher resolution, so fine shape information survives into generation instead of being averaged out. The training data was rebuilt to a stricter standard, every sample corresponding exactly to its target geometry with style, lighting and background removed. And geometry alignment became a tracked signal inside every training cycle rather than an evaluation applied at the end — the capability users care about and the number the team optimises against are now the same number.

HOW ALIGNMENT IS MEASURED

The benchmark uses neither human preference nor a vision-language judge; it compares 3D geometry directly.

Reference 3D models held out of training are rendered into input images using known cameras. Each generative model produces a 3D result from those images, which is compared against the original reference geometry — so every test image has a known 3D correct answer. Comparing renders instead would mean estimating the source camera first, mixing camera error into the geometry error being measured.

Before scoring, each generation is aligned to its reference by translation, rotation and uniform scaling only — never stretched along a single axis, so a model’s own proportion errors cannot be corrected away. Agreement is then measured at three levels, from overall structure down to fine geometric difference. The reference set spans characters, vehicles, sculptures and thin-structure props, tested under three input conditions: front view, raised top-quarter view, and four views combined.

AVAILABILITY AND WHAT COMES NEXT

Meshy 7 went live on 10 August, open to all Meshy subscription tiers; downloading generated models requires the Pro tier or above. Ultra Mode currently supports single-view generation, with multi-view support arriving shortly. The benchmark described here will be released separately after launch. Geometry is only part of image-to-3D alignment — colour, material and pattern have their own — and a dedicated texture alignment benchmark will follow.

View original content to download multimedia:https://www.prnewswire.com/news-releases/meshy-releases-meshy-7-a-new-foundation-model-that-sets-a-new-bar-for-image-3d-alignment-302849368.html

SOURCE Meshy

Continue Reading

Technology

The NYSE Welcomes vVARDIS as a Publicly Listed Company

Published

on

By

NEW YORK, Nov. 14, 2026 /PRNewswire/ — vVARDIS (NYSE: VVVV) co-founders Dr. Haley Abivardi and Dr. Goly Abivardi aim to reshape the future of dental care with a drill-free treatment for the world’s #1 non-communicable disease: cavities.

vVARDIS Solves a Problem that Millions FaceTooth decay affects billions of people worldwide, and dental anxiety keeps millions from getting the care they need.vVARDIS is a Swiss dental technology company focused on changing the way early tooth decay is treated.vVARDIS has introduced a new approach that aims to treat decay earlier and more comfortably for patients.Its flagship product, Curodont® Repair Fluoride Plus, uses proprietary peptide technology to help repair early-stage tooth decay by supporting the natural remineralization of enamel — simply put No drill, No needle, or No filling.Tooth Decay is One of the Most Common Health Issues in the World2.5 billion people globally live with untreated tooth decay.Nearly 90% of U.S. adults have experienced tooth decay.Nearly 73% of U.S. adults report dental fear.21% avoid the dentist because of anxiety.The Story that Helped Shape vVARDISFor decades, treating early tooth decay often meant waiting until it worsened or getting a filling. The founders spent 25 years developing Curodont® Repair Fluoride Plus, a treatment that helps repair early tooth decay before it becomes a cavity.Curodont® gives dentists a way to treat early decay while making the experience easier and less intimidating for patients.The technology has already treated more than 2.5 million teethAvailable in more than 20% of U.S. dental practices

Click Here to Learn More about vVARDIS: https://www.youtube.com/watch?v=T1p9hUR5Glk

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/the-nyse-welcomes-vvardis-as-a-publicly-listed-company-302939487.html

SOURCE New York Stock Exchange

Continue Reading

Technology

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

Published

on

By

SHANGHAI, Nov. 14, 2026 /PRNewswire/ — Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13, 2026. Windward Bio (Nasdaq: WWB) priced its IPO at $17.00 per share. Its shares closed at $28.50 on the first trading day, up 68% from the IPO price, giving the company a market capitalization of approximately $1.69 billion. This is Qiming Venture Partners’ 11th IPO in 2026.

Qiming Venture Partners invested in Windward Bio’s inaugural Series A financing in 2025 and continued to support the company in its Series B financing in 2026. Qiming also participated in this IPO financing round.

Windward Bio was founded in 2024 with a mission to transform the treatment paradigm for patients living with chronic inflammatory diseases through the development of differentiated biologic therapies targeting clinically validated disease pathways. Led by a team with extensive expertise across discovery, development, and commercialization, Windward Bio is advancing a pipeline of ultra-long-acting antibody medicines to improve clinical outcomes, reduce treatment burden and expand treatment options for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease (COPD) and atopic dermatitis.

Windward Bio’s lead program, WIN378, is a potentially novel anti-TSLP monoclonal antibody engineered for improved potency and extended half-life. WIN378 is currently being evaluated in POLARIS-1, a Phase 2/3 study in severe uncontrolled asthma, and SIRIUS, a Phase 2 study in COPD. The company’s pipeline also includes WIN027, a clinical-stage, long-acting bispecific antibody targeting TSLP and IL-13 with potential applications across multiple inflammatory and immunological diseases. Windward Bio holds exclusive global rights (excluding Greater China and certain Asian countries) to WIN378 through a licensing agreement with Kelun-Biotech and Harbour BioMed, and has separately licensed WIN027 from Qyuns Therapeutics.

“Qiming Venture Partners invests in differentiated, globally competitive biotech innovation designed to address significant unmet needs for patients, and Windward Bio exemplifies this approach. We believe novel, long-acting biologics will reshape the treatment of severe chronic respiratory and skin diseases, and that WIN378 and WIN027 have the potential to expand and meaningfully improve the treatment options available to patients. In the hands of Luca and his team, with their expertise and proven track record, Windward is well-positioned to deliver on this potential, and we look forward to supporting the company through its next phase of growth,” said Alexander Sinclair Wilson, Principal at Qiming Venture Partners.

About Qiming Venture Partners

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages.

Since our debut, we have backed over 630 fast-growing and innovative companies. Over 290 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 110 portfolio companies that have achieved unicorn or super unicorn status.

Many of our portfolio companies are today’s most influential firms in their respective sectors, including Xiaomi, Meituan, Bilibili, Zhihu, Roborock, Hesai Technology, UBTech, WeRide, HyperStrong, Insta360, Unisound, Biren Technology, Z.AI, Gan & Lee Pharmaceuticals, Tigermed, Zai Lab, CanSino Biologics, Schrödinger, APT Medical, Sanyou Medical, AmoyDx, SinocellTech, Insilico Medicine, AusperBio, Yuanxin Technology, Medilink Therapeutics, LaNova Medicines, StepFun, among many others.

 

View original content:https://www.prnewswire.com/news-releases/innovative-immunology-biotech-windward-bio-lists-on-nasdaq-302939481.html

SOURCE Qiming Venture Partners

Continue Reading

Technology

WeFetch AI Corp. Is the New Name of GreenCore Solutions Corp.

Published

on

By

gtinfetch.ai, WeFetch.ai’s lead product, removes the guess from artificial intelligence (AI) shopping: the right barcode, and signed proof of it.

VANCOUVER, BC and LONDON, Nov. 13, 2026 /PRNewswire/ — WeFetch AI Corp., the artificial intelligence (AI) shopping company formerly named GreenCore Solutions Corp., has completed its change of name. The Registrar of Companies for British Columbia issued the Certificate of Change of Name on November 13, 2026.

One Answer for Every Barcode

An AI agent picks a product in words. The same words can match a dozen barcodes: the right brand in the wrong size, last year’s pack, a look-alike from another maker. When the agent guesses, the shopper gets the wrong product, the brand loses a sale it had already won, and the retailer pays for the return.

The Company’s lead product, gtinfetch.ai, removes the guess. It answers for 84,810,515 barcodes from 376,271 makers across 3,520,471 points of sale. An AI agent sends a barcode and gets a firm answer: verified, not verified or unknown, with the sources behind it.

Who it matters to:

The shopper gets the product they asked for.The brand keeps the sale the AI already gave it.The retailer does not pay for a wrong order.

A Signed Receipt of Every Check

When an AI agent buys on a shopper’s behalf, someone has to be able to show it bought the right product. Today nobody can: the agent’s choice leaves no record. gtinfetch.ai gives the agent a signed receipt of the check, written at rco.wefetch.ai and open to public verification. The retailer, the brand and the auditor can each see what was checked, when, and what the answer was. The mark is “Barcode verified”.

Three Regions, One Record

The full record now answers from France, Singapore and the United States. Every barcode also has its own free public page at gtinfetch.ai. The three regions are where AI shopping starts. Singapore has the highest consumer use of generative AI in Asia, at 64.3% of working-age people. France stands at 49.6% and the United States at 33.0%, against 18.8% worldwide. (Source: Microsoft AI Diffusion Report, Q2 2026.) They are also the home markets of the AI that shoppers ask: ChatGPT and Claude in the United States, Mistral in France, and Singapore among the top countries in the world for Claude use per head. (Source: Anthropic Economic Index.)

What we built

WeFetch.ai, the barcode fetch system for AI agents. It answers for 84 million products in 70 countries, with 3.5 million points of sale on its own record, and includes:

triggerfetch for brands;shopfetch for shoppers;matchfetch for AI agents;gtinfetch, the record itself.

It is AI native, and works with ChatGPT, Claude, Gemini, Grok, Mistral, Perplexity and Muse. Every answer is signed.

“Words were the first generation of AI answers. Barcodes are agentic commerce,” said Matthew Keddy, Chief Executive Officer of WeFetch AI Corp. “Every AI agent that moves from search results to shopping needs barcode precision. wefetch has it, signed, in three regions.”

The market: Gartner forecasts $2.7 trillion in AI spending in 2026. McKinsey projects that AI agents will orchestrate $3 trillion to $5 trillion in global commerce by 2030, up to $1 trillion of it in US retail. Every one of those AI agent purchases needs the right barcode.

About WeFetch AI Corp.

WeFetch AI Corp. develops AI software products for AI shopping, retail, grocery and fast-moving consumer goods (FMCG). Its lead product, gtinfetch.ai, is the AI agentic shopping barcode engine: 84 million barcodes, answered for the agents of seven AI labs. WeFetch is headquartered in Vancouver, Canada, with sales offices in London, UK. Please visit: wefetch.ai

View original content:https://www.prnewswire.com/news-releases/wefetch-ai-corp-is-the-new-name-of-greencore-solutions-corp-302939459.html

SOURCE Greencore Solutions Corp.

Continue Reading

Trending